Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| JOHNSON & JOHNSONJNJ · Entity 2722 | Vice Chair, Exec Committee | February 12, 2021 | February 18, 2021 |
| TAKEDA PHARMACEUTICAL CO LTDTAK · Entity 2662 | Director | July 01, 2026 | July 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
JOHNSON & JOHNSON
Report date February 12, 2021 · Filed February 18, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 275,547.3732 |
Ending reported balance
After 2021-02-12 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2021-02-12 · Exercise / conversion · Acquired 29,452 · Balance 284,254.3732 F1: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 12, 2018; converted into shares of Common Stock upon vesting. Row 2 · 2021-02-12 · Exercise / conversion · Acquired 5,610 · Balance 289,864.3732 F2: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 12, 2018; converted into shares of Common Stock upon vesting. Row 3 · 2021-02-12 · Tax withholding · Disposed 1,592 · Balance 288,272.3732 F3: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Row 4 · 2021-02-12 · Tax withholding · Disposed 12,725 · Balance 275,547.3732 F4: Shares withheld for payment of taxes upon vesting of Performance Share Units. |
| Performance Share UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-02-12 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2021-02-12 · Exercise / conversion · Disposed 29,452 · Balance 0 F1: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 12, 2018; converted into shares of Common Stock upon vesting. |
| Restricted Share UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-02-12 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2021-02-12 · Exercise / conversion · Disposed 5,610 · Balance 0 F2: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 12, 2018; converted into shares of Common Stock upon vesting. |
Filing footnotes · ownership attribution and instrument terms
F1: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 12, 2018; converted into shares of Common Stock upon vesting.
F2: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 12, 2018; converted into shares of Common Stock upon vesting.
F3: Shares withheld for payment of taxes upon vesting of Restricted Share Units.
F4: Shares withheld for payment of taxes upon vesting of Performance Share Units.
TAKEDA PHARMACEUTICAL CO LTD
Report date July 01, 2026 · Filed July 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 3,800 |
Reported balance
After 2026-07-01 transaction · row 1
1 source rowRow 1 · 2026-07-01 · Grant · Acquired 3,800 · Balance 3,800 F1: Represents an award of restricted stock units (RSU). Each RSU represents a contingent right to receive one Ordinary Share, which will be converted into an equivalent number of American Depositary Shares following vest. The RSUs vest on June 1, 2029. |
| Tax Obligation AwardSEC Table II · derivative / convertible security · Expires 2029-06-01 | Direct | 1,307 |
Reported balance
After 2026-07-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-07-01 · Grant · Acquired 1,307 · Balance 1,307 F2: Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of restricted stock units (RSU). Each RSU represents a contingent right to receive one Ordinary Share, which will be converted into an equivalent number of American Depositary Shares following vest. The RSUs vest on June 1, 2029.
F2: Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 13, 2017 Filed Feb 16, 2017 11:01 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantEmployee Stock Options (Right to Buy) · Derivative | 138,982 | $0.00 Strike: $115.67 | $0.00 |
DisclosureSEC source: 0001225208-17-003494 · doc4.xml · derivative · entry 4 Stoffels Paulus · CIK 0001559387 · Exec VP, Chief Scientific Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,982 Underlying: Common Stock · 138,982 shares Expires 2027-02-13 F4 · security: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 13, 2017 Filed Feb 16, 2017 11:01 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Tax withholdingCommon Stock | 17,027 | $115.67 | $1,969,513.09 |
DisclosureSEC source: 0001225208-17-003494 · doc4.xml · nonDerivative · entry 3 Stoffels Paulus · CIK 0001559387 · Exec VP, Chief Scientific Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,650.416 F3 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 13, 2017 Filed Feb 16, 2017 11:01 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantCommon Stock | 10,552 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-003494 · doc4.xml · nonDerivative · entry 2 Stoffels Paulus · CIK 0001559387 · Exec VP, Chief Scientific Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,677.416 F2 · shares: Shares earned due to performance factor of 139.9% upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 13, 2017 Filed Feb 16, 2017 11:01 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 26,447 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-003494 · doc4.xml · nonDerivative · entry 1 Stoffels Paulus · CIK 0001559387 · Exec VP, Chief Scientific Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,125.416 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 10, 2014 converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 22:49 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionRestricted Share Units · Derivative | 10,579 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-003264 · doc4.xml · derivative · entry 3 Stoffels Paulus · CIK 0001559387 · Exec VP, Chief Scientific Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,579 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on February 10, 2014, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. F1 · derivative.expiration_date: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on February 10, 2014, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 22:49 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Tax withholdingCommon Stock | 3,600 | $115.13 | $414,468.00 |
DisclosureSEC source: 0001225208-17-003264 · doc4.xml · nonDerivative · entry 2 Stoffels Paulus · CIK 0001559387 · Exec VP, Chief Scientific Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,678.416 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 22:49 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 10,579 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-003264 · doc4.xml · nonDerivative · entry 1 Stoffels Paulus · CIK 0001559387 · Exec VP, Chief Scientific Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,278.416 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on February 10, 2014, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. Read SEC document |
| February 17, 2016 Filed Feb 19, 2016 21:43 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 125,000 | $0.00 Strike: $72.54 | $0.00 |
DisclosureSEC source: 0001225208-16-027117 · doc4.xml · derivative · entry 3 Stoffels Paulus · CIK 0001559387 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,692 Underlying: Common Stock · 125,000 shares Expires 2023-01-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2016 Filed Feb 19, 2016 21:43 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | SaleCommon Stock | 125,000 | $102.43 | $12,803,250.00 |
DisclosureSEC source: 0001225208-16-027117 · doc4.xml · nonDerivative · entry 2 Stoffels Paulus · CIK 0001559387 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,543.0723 F1 · price: This transaction was executed in multiple trades at prices ranging from $102.305 to $102.48. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 17, 2016 Filed Feb 19, 2016 21:43 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 125,000 | $72.54 | $9,067,500.00 |
DisclosureSEC source: 0001225208-16-027117 · doc4.xml · nonDerivative · entry 1 Stoffels Paulus · CIK 0001559387 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 247,543.0723 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 08, 2016 Filed Feb 10, 2016 23:03 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantRestricted Share Units · Derivative | 12,571 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-026033 · doc4.xml · derivative · entry 6 Stoffels Paulus · CIK 0001559387 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,571 Underlying: Common Stock · 12,571 shares Expires not disclosed F5 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F5 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 08, 2016 Filed Feb 10, 2016 23:03 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionPerformance Share Units · Derivative | 28,242 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-026033 · doc4.xml · derivative · entry 5 Stoffels Paulus · CIK 0001559387 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 28,242 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on January 16, 2013 converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. F1 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on January 16, 2013 converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 08, 2016 Filed Feb 10, 2016 23:03 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantEmployee Stock Options (Right to Buy) · Derivative | 174,787 | $0.00 Strike: $101.87 | $0.00 |
DisclosureSEC source: 0001225208-16-026033 · doc4.xml · derivative · entry 4 Stoffels Paulus · CIK 0001559387 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,787 Underlying: Common Stock · 174,787 shares Expires 2026-02-07 F4 · security: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 08, 2016 Filed Feb 10, 2016 23:03 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Tax withholdingCommon Stock | 16,779 | $101.87 | $1,709,276.73 |
DisclosureSEC source: 0001225208-16-026033 · doc4.xml · nonDerivative · entry 3 Stoffels Paulus · CIK 0001559387 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,543.0723 F3 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 08, 2016 Filed Feb 10, 2016 23:03 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantCommon Stock | 8,218 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-026033 · doc4.xml · nonDerivative · entry 2 Stoffels Paulus · CIK 0001559387 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,322.0723 F2 · shares: Shares earned due to performance factor of 129.1% upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 08, 2016 Filed Feb 10, 2016 23:03 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 28,242 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-026033 · doc4.xml · nonDerivative · entry 1 Stoffels Paulus · CIK 0001559387 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,104.0723 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on January 16, 2013 converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| January 15, 2016 Filed Jan 21, 2016 00:25 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionRestricted Share Units · Derivative | 11,297 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-024574 · doc4.xml · derivative · entry 3 Stoffels Paulus · CIK 0001559387 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,297 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on January 16, 2013, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. F2 · derivative.expiration_date: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on January 16, 2013, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. Read SEC document |
| January 15, 2016 Filed Jan 21, 2016 00:25 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Tax withholdingCommon Stock | 3,723 | $97.12 | $361,577.76 |
DisclosureSEC source: 0001225208-16-024574 · doc4.xml · nonDerivative · entry 2 Stoffels Paulus · CIK 0001559387 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,862.0723 F3 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| January 15, 2016 Filed Jan 21, 2016 00:25 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 11,297 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-024574 · doc4.xml · nonDerivative · entry 1 Stoffels Paulus · CIK 0001559387 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,585.0723 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Includes dividends automatically reinvested into additional shares of common stock. F2 · price: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on January 16, 2013, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 20:56 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 19,109 | $0.00 Strike: $61.75 | $0.00 |
DisclosureSEC source: 0001225208-15-010720 · doc4.xml · derivative · entry 9 Stoffels Paulus · CIK 0001559387 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,109 shares Expires 2018-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 20:56 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 24,521 | $0.00 Strike: $62.62 | $0.00 |
DisclosureSEC source: 0001225208-15-010720 · doc4.xml · derivative · entry 8 Stoffels Paulus · CIK 0001559387 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 24,521 shares Expires 2020-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 20:56 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 160,133 | $0.00 Strike: $65.37 | $0.00 |
DisclosureSEC source: 0001225208-15-010720 · doc4.xml · derivative · entry 7 Stoffels Paulus · CIK 0001559387 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 160,133 shares Expires 2022-01-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 20:56 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 24,920 | $0.00 Strike: $62.20 | $0.00 |
DisclosureSEC source: 0001225208-15-010720 · doc4.xml · derivative · entry 6 Stoffels Paulus · CIK 0001559387 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 24,920 shares Expires 2021-01-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 20:56 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | SaleCommon Stock | 187,250 | $100.73 | $18,862,141.90 |
DisclosureSEC source: 0001225208-15-010720 · doc4.xml · nonDerivative · entry 5 Stoffels Paulus · CIK 0001559387 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,473.456 F1 · kind: Shares sold to cover exercise price and taxes owed upon exercise of option. F2 · price: This transaction was executed in multiple trades at prices ranging from $100.63 to $100.92. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 20:56 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 19,109 | $61.75 | $1,179,980.75 |
DisclosureSEC source: 0001225208-15-010720 · doc4.xml · nonDerivative · entry 4 Stoffels Paulus · CIK 0001559387 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 281,723.456 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 20:56 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 24,521 | $62.62 | $1,535,505.02 |
DisclosureSEC source: 0001225208-15-010720 · doc4.xml · nonDerivative · entry 3 Stoffels Paulus · CIK 0001559387 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262,614.456 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 20:56 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 24,920 | $62.20 | $1,550,024.00 |
DisclosureSEC source: 0001225208-15-010720 · doc4.xml · nonDerivative · entry 2 Stoffels Paulus · CIK 0001559387 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 238,093.456 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 20:56 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 160,133 | $65.37 | $10,467,894.21 |
DisclosureSEC source: 0001225208-15-010720 · doc4.xml · nonDerivative · entry 1 Stoffels Paulus · CIK 0001559387 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213,173.456 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 09, 2015 Filed Feb 12, 2015 01:16 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantRestricted Share Units · Derivative | 13,252 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-15-003647 · doc4.xml · derivative · entry 6 Stoffels Paulus · CIK 0001559387 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,252 Underlying: Common Stock · 13,252 shares Expires not disclosed F5 · security: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F5 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F5 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 09, 2015 Filed Feb 12, 2015 01:16 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionPerformance Share Units · Derivative | 29,073 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-15-003647 · doc4.xml · derivative · entry 5 Stoffels Paulus · CIK 0001559387 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 29,073 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on January 17, 2012 converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. F4 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on January 17, 2012 converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. F4 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on January 17, 2012 converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 09, 2015 Filed Feb 12, 2015 01:16 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantEmployee Stock Options (Right to Buy) · Derivative | 170,668 | $0.00 Strike: $100.06 | $0.00 |
DisclosureSEC source: 0001225208-15-003647 · doc4.xml · derivative · entry 4 Stoffels Paulus · CIK 0001559387 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,668 Underlying: Common Stock · 170,668 shares Expires 2025-02-08 F3 · security: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 09, 2015 Filed Feb 12, 2015 01:16 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Tax withholdingCommon Stock | 14,892 | $100.06 | $1,490,093.52 |
DisclosureSEC source: 0001225208-15-003647 · doc4.xml · nonDerivative · entry 3 Stoffels Paulus · CIK 0001559387 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,040.456 F2 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 09, 2015 Filed Feb 12, 2015 01:16 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantCommon Stock | 3,285 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-15-003647 · doc4.xml · nonDerivative · entry 2 Stoffels Paulus · CIK 0001559387 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,932.456 F1 · shares: Shares earned due to performance factor of 111.3% upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 09, 2015 Filed Feb 12, 2015 01:16 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 29,073 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-15-003647 · doc4.xml · nonDerivative · entry 1 Stoffels Paulus · CIK 0001559387 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,647.456 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 16, 2015 Filed Jan 21, 2015 22:48 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionRestricted Share Units · Derivative | 11,629 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-15-001734 · doc4.xml · derivative · entry 3 Stoffels Paulus · CIK 0001559387 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,629 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on January 17, 2012, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. F2 · derivative.expiration_date: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on January 17, 2012, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. Read SEC document |
| January 16, 2015 Filed Jan 21, 2015 22:48 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Tax withholdingCommon Stock | 3,965 | $103.32 | $409,663.80 |
DisclosureSEC source: 0001225208-15-001734 · doc4.xml · nonDerivative · entry 2 Stoffels Paulus · CIK 0001559387 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,574.456 F1 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| January 16, 2015 Filed Jan 21, 2015 22:48 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 11,629 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-15-001734 · doc4.xml · nonDerivative · entry 1 Stoffels Paulus · CIK 0001559387 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,539.456 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 31, 2014 Filed Nov 4, 2014 22:33 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantRestricted Share Units · Derivative | 75,492 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-14-022735 · doc4.xml · derivative · entry 1 Stoffels Paulus · CIK 0001559387 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,492 Underlying: Common Stock · 75,492 shares Expires not disclosed F1 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F1 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 10, 2014 Filed Feb 12, 2014 23:14 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantPerformance Share Units · Derivative | 26,447 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-14-000014 · edgar.xml · derivative · entry 4 Stoffels Paulus · CIK 0001559387 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,447 Underlying: Common Stock · 26,447 shares Expires not disclosed F4 · security: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units convert into shares of Common Stock upon distribution in the first quarter of 2017 based on a performance factor F4 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units convert into shares of Common Stock upon distribution in the first quarter of 2017 based on a performance factor F4 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units convert into shares of Common Stock upon distribution in the first quarter of 2017 based on a performance factor F4 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units convert into shares of Common Stock upon distribution in the first quarter of 2017 based on a performance factor Read SEC document |
| February 10, 2014 Filed Feb 12, 2014 23:14 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantRestricted Share Units · Derivative | 10,579 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-14-000014 · edgar.xml · derivative · entry 3 Stoffels Paulus · CIK 0001559387 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,579 Underlying: Common Stock · 10,579 shares Expires not disclosed F3 · security: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F3 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F3 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 10, 2014 Filed Feb 12, 2014 23:14 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantEmployee Stock Options (Right to Buy) · Derivative | 155,342 | $0.00 Strike: $90.44 | $0.00 |
DisclosureSEC source: 0000200406-14-000014 · edgar.xml · derivative · entry 2 Stoffels Paulus · CIK 0001559387 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,342 Underlying: Common Stock · 155,342 shares Expires 2024-02-09 F2 · security: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| January 10, 2014 Filed Jan 14, 2014 23:03 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionRestricted Share Units · Derivative | 18,690 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-14-000005 · edgar.xml · derivative · entry 3 Stoffels Paulus · CIK 0001559387 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,690 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on January 10, 2011, represents a contingent right to receive one share of Common Stock, and vests three years after date of grant. F3 · derivative.expiration_date: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on January 10, 2011, represents a contingent right to receive one share of Common Stock, and vests three years after date of grant. Read SEC document |
| January 10, 2014 Filed Jan 14, 2014 23:03 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Tax withholdingCommon Stock | 8,150 | $94.53 | $770,419.50 |
DisclosureSEC source: 0000200406-14-000005 · edgar.xml · nonDerivative · entry 2 Stoffels Paulus · CIK 0001559387 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,453 F2 · shares: Shares withheld for the payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| January 10, 2014 Filed Jan 14, 2014 23:03 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 18,690 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-14-000005 · edgar.xml · nonDerivative · entry 1 Stoffels Paulus · CIK 0001559387 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,603 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: 330 shares held under Issuer's Dividend Reinvestment Plan. Read SEC document |
| July 25, 2013 Filed Jul 29, 2013 21:51 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 29,168 | $0.00 Strike: $65.62 | $0.00 |
DisclosureSEC source: 0000200406-13-000088 · edgar.xml · derivative · entry 6 Stoffels Paulus · CIK 0001559387 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 29,168 shares Expires 2017-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Awarded under Issuer's Stock Option Plan and exercisable in full starting one day after the third anniversary of the grant. Read SEC document |
| July 25, 2013 Filed Jul 29, 2013 21:51 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 24,000 | $0.00 Strike: $66.18 | $0.00 |
DisclosureSEC source: 0000200406-13-000088 · edgar.xml · derivative · entry 5 Stoffels Paulus · CIK 0001559387 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 24,000 shares Expires 2015-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Awarded under Issuer's Stock Option Plan and exercisable in full starting one day after the third anniversary of the grant. Read SEC document |
| July 25, 2013 Filed Jul 29, 2013 21:51 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | SaleCommon Stock | 24,900 | $92.40 | $2,300,760.00 |
DisclosureSEC source: 0000200406-13-000088 · edgar.xml · nonDerivative · entry 4 Stoffels Paulus · CIK 0001559387 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,801 F2 · shares: Shares sold to cover exercise price and taxes owed upon exercise of option. F3 · price: This transaction was executed in multiple trades at prices ranging from $92.39 to $92.43. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide unpon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: 218 shares held under Issuer's Dividend Reinvestment Plan. Read SEC document |
| July 25, 2013 Filed Jul 29, 2013 21:51 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 29,168 | $65.62 | $1,914,004.16 |
DisclosureSEC source: 0000200406-13-000088 · edgar.xml · nonDerivative · entry 3 Stoffels Paulus · CIK 0001559387 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,701 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: 218 shares held under Issuer's Dividend Reinvestment Plan. Read SEC document |
| July 25, 2013 Filed Jul 29, 2013 21:51 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | SaleCommon Stock | 20,540 | $92.40 | $1,897,896.00 |
DisclosureSEC source: 0000200406-13-000088 · edgar.xml · nonDerivative · entry 2 Stoffels Paulus · CIK 0001559387 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,533 F2 · shares: Shares sold to cover exercise price and taxes owed upon exercise of option. F3 · price: This transaction was executed in multiple trades at prices ranging from $92.39 to $92.43. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide unpon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: 218 shares held under Issuer's Dividend Reinvestment Plan. Read SEC document |
| July 25, 2013 Filed Jul 29, 2013 21:51 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 24,000 | $66.18 | $1,588,320.00 |
DisclosureSEC source: 0000200406-13-000088 · edgar.xml · nonDerivative · entry 1 Stoffels Paulus · CIK 0001559387 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,073 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: 218 shares held under Issuer's Dividend Reinvestment Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.